BELLUSCURA PLC

Capital/Financing Update • Sep 22, 2025

National Storage Mechanism | Additional information

RNS Number : 2184A

Belluscura PLC

22 September 2025

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

22 September 2025

Belluscura plc

(" Belluscura " or the " Company ")

Update regarding Proposed Funding

Board changes

Belluscura plc (AIM:BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that, further to the statement issued on 12 September 2025, discussions with Omaha Value, Inc. and a connected company called AI Ventures, Inc, regarding the proposed fundraising, have not yet been concluded as anticipated. Discussions have continued, however, with Omaha Value, Inc, AI Ventures, Inc and other potential investors with a view to the refinancing of Belluscura and Belluscura LLC, the Company's main trading subsidiary.

As a result, Belluscura LLC has taken steps to enable it to meet its immediate cash requirements.  Whilst the senior management team and those employees responsible for Sales and Shipping have been retained, to ensure the continued fulfilment of customer orders, the employment contracts of 15 of Belluscura LLC's 25 employees in the United States have been terminated .

Board changes

The Company also announces that Bob Rauker remains CEO of Belluscura LLC but has resigned from the board of Belluscura with immediate effect.

Ric Piper, who has been a Director of Belluscura since its AIM flotation in 2021, has also resigned as a non-executive director of Belluscura with immediate effect.

The ongoing funding discussions mean that the Company is still not yet able to finalise the 2024 Annual Report and Accounts and as a result trading in the Company's shares on AIM remains suspended.

A further announcement will be made in due course.

For further information please contact:

Belluscura plc	Tel: +44 (0)20 3128 8100
Paul Tuson, Chairman
SPARK Advisory Partners Limited - Nominated Adviser	Tel: +44 (0)20 3368 3550
Neil Baldwin / Dillon Wall
Dowgate Capital Limited - Joint Broker	Tel: +44 (0)20 3903 7715
Russell Cook / Daniel Ingram
Allenby Capital Limited - Joint Broker	Tel: +44 (0)20 3328 5656
Guy McDougall / Amrit Nahal (Sales and Corporate Broking)
Jeremy Porter / Lauren Wright (Corporate Finance)
MHP - Financial PR & Investor Relations	Tel: +44 (0)20 3128 8100
Katie Hunt / Matthew Taylor	email: [email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAPKDBDBBKBFCB